Propanc Biopharma, Inc. (PPCB) — 10-Q Filings
All 10-Q filings from Propanc Biopharma, Inc.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
Propanc Biopharma's Q1 Loss Skyrockets on Soaring Admin Costs
— Nov 14, 2025 Risk: high
Propanc Biopharma, Inc. (PPCB) reported a significant increase in net loss for the three months ended September 30, 2025, reaching **$4,837,738**, a substantial -
Propanc Biopharma Files 10-Q for Q3 2025
— May 15, 2025 Risk: medium
Propanc Biopharma, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial information and business operations for the third quar -
Propanc Biopharma Files 10-Q for Q2 FY2025
— Feb 14, 2025 Risk: medium
Propanc Biopharma, Inc. filed its 10-Q for the period ending December 31, 2024. The filing covers the second quarter of their fiscal year. Key financial data an -
Propanc Biopharma Files Q1 2025 10-Q
— Nov 14, 2024 Risk: medium
Propanc Biopharma, Inc. filed a 10-Q for the period ending September 30, 2024. The filing details financial information and business operations for the first qu -
Propanc Biopharma, Inc. Files 10-Q for Period Ending March 31, 2024
— May 15, 2024 Risk: low
Propanc Biopharma, Inc. (PPCB) filed a Quarterly Report (10-Q) with the SEC on May 15, 2024. Propanc Biopharma, Inc. filed a 10-Q report for the quarter ended M -
Propanc Biopharma, Inc. Files 10-Q for Period Ending December 31, 2023
— Feb 20, 2024 Risk: medium
Propanc Biopharma, Inc. (PPCB) filed a Quarterly Report (10-Q) with the SEC on February 20, 2024. Propanc Biopharma, Inc. filed a 10-Q report for the period end
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX